Non small cell lung cancer

• Health & Medicine

Almost 2,000 lung cancer patients missing out on surgery every year

Around 1,800 lung cancer patients may be missing out on life-saving surgery each year, according to new statistics from Cancer Research UK. Around 1,800 lung cancer patients may be missing out on life-saving surgery each year, according to new statistics from Cancer Research UK.

24 October 2014

• Science & Technology

Researchers reveal lung cancer can stay hidden for over 20 years

Scientists have discovered that lung cancers can lie dormant for over 20 years before suddenly turning into an aggressive form of the disease Scientists have discovered that lung cancers can lie dormant for over 20 years before suddenly turning into an aggressive form of the disease

9 October 2014

• Health & Medicine

Aspirin could combat permanent hearing loss caused by cancer drug

Cancer Research UK has launched a new trial to see if high doses of aspirin might help avoid hearing loss in patients given the drug cisplatin. Cancer Research UK has launched a new trial to see if high doses of aspirin might help avoid hearing loss in patients given the drug cisplatin.

8 May 2014

• Health & Medicine

Revolutionary clinical trial aims to advance lung cancer treatment thanks to Cancer Research UK and Pharma partnership

Cancer Research UK is partnering with pharmaceutical companies to create a pioneering clinical trial for patients with advanced lung cancer  Cancer Research UK is partnering with pharmaceutical companies to create a pioneering clinical trial for patients with advanced lung cancer 

17 April 2014

• Health & Medicine

Experimental breast cancer drug to be trialled in lung cancer patients

A clinical trial using an experimental drug originally designed to treat breast cancer launches for patients with advanced lung cancer  A clinical trial using an experimental drug originally designed to treat breast cancer launches for patients with advanced lung cancer 

11 March 2014

• Health & Medicine

New research to revolutionise understanding of lung cancer

In a world first, a new Cancer Research UK study will unlock lung cancer's secrets, tracking in real time how lung tumours develop and evolve as patients receive treatment. In a world first, a new Cancer Research UK study will unlock lung cancer's secrets, tracking in real time how lung tumours develop and evolve as patients receive treatment.

18 July 2013

Genetic screen finds new treatment targets for lung cancer

Cancer Research UK scientists are the first to use an efficient new screening strategy to identify gene faults in tumour cells that are possible drug targets for the most common form of lung cancer, according to new research published in PNAS. Cancer Research UK scientists are the first to use an efficient new screening strategy to identify gene faults in tumour cells that are possible drug targets for the most common form of lung cancer, according to new research published in PNAS.

8 July 2013

• Health & Medicine

Diabetes drug makes lung cancer vulnerable to radiotherapy

The diabetes drug metformin slows the growth of lung cancer cells and makes them more likely to be killed by radiotherapy. The diabetes drug metformin slows the growth of lung cancer cells and makes them more likely to be killed by radiotherapy.

1 May 2013

• Health & Medicine

Skin rash predicts survival benefit from latest lung cancer drug

Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, compared to 4.1 months for patients who were given a placebo, results from a major phase III Cancer Research UK-funded trial show today (Tuesday). Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, compared to 4.1 months for patients who were given a placebo, results from a major phase III Cancer Research UK-funded trial show today (Tuesday).

16 October 2012

Existing drugs could treat smokers' lung cancer

A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (NSCLC), according to a study published in Cell today A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (NSCLC), according to a study published in Cell today

26 April 2012

• Health & Medicine

Cancer Research UK leads global lung cancer drug trial

Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The trial will take place at the Oxford Radcliffe Hospitals NHS Trust. Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The trial will take place at the Oxford Radcliffe Hospitals NHS Trust.

29 March 2011

• Science & Technology

Counting lung cancer cells opens window on disease

CANCER RESEARCH UK scientists have found that counting the number of lung cancer cells circulating in the blood could determine how aggressive the cancer is and predict the best treatment to use. CANCER RESEARCH UK scientists have found that counting the number of lung cancer cells circulating in the blood could determine how aggressive the cancer is and predict the best treatment to use.

21 March 2011